The US Food and Drug Administration (FDA) is seeking public feedback on whether its scale-up and post-approval changes (SUPAC) guidance documents for the pharmaceutical industry need to be updated and ...
Scale-UP and Post Approval Changes (SUPAC) is an integral part of pharmaceutical product development but till a few years ago, no guidance was Scale-UP and Post Approval Changes (SUPAC) is an integral ...
Draft guidance combines and supersedes previous guidance documents. Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and ...
The US Food and Drug Administration (FDA) has released a new final guidance document regarding how manufacturers of pharmaceutical products can make changes to their manufacturing equipment under ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results